Please join us on October 3rd from 12:15pm - 1:15pm for a Q&A from Wesley and Sebastian from 8vc. They will be here to talk about venture capital and healthcare technology. Bring your lunch, come learn and come ask questions! Space is limited, so please RSVP to Patty.Dawson@Tufts.edu if you are interested in joining.
Wesley Friedman is an investor at 8VC focused primarily on healthcare technology.
Previously, Wesley was a Senior Associate of Business Strategy & Operations at Celmatix, a healthcare technology company operating at the nexus of genomics and big data, with a particular focus on therapeutics for reproductive health conditions. Wesley currently serves as a member of the Board of Directors and Vice President of Harvard Alumni in Healthcare and was an Executive Board Member of the Leadership Institute of Harvard College.
Wesley graduated from Harvard College, receiving his AB degree, cum laude, in History & Science. Wesley is originally from Los Angeles, CA.
Sebastian invests in both the consumer and enterprise space at 8VC with a focus on healthcare.
Prior to 8VC, Sebastian spent over 4 years at Palantir where he was responsible for growing the commercial healthcare business and helped numerous insurance, pharmaceutical, and provider clients solve their hardest data analysis problems. He additionally served as an independent consultant to several health IT startups, advising on product and commercial strategy. He began his career as an analyst at Mithril Capital Management and at Breakout Labs.
Sebastian often writes on health policy and his work has been featured on Axios. In his spare time, Sebastian also conducts nutrition research at Stanford and has served on the board of Learning Unlimited, a Cambridge, MA education nonprofit where he remains active.
Sebastian completed a year of the MD program at Stanford University and holds a BS and MS, magna cum laude, in Molecular Biophysics & Biochemistry from Yale University. Sebastian is originally from Andover, MA.